Shots:

• The public-private collaboration will expand Janssen’s ongoing work with global partners to screen a library of existing antiviral molecules- with the goal to identify compounds with antiviral activity against SARS-CoV-2
• As per the collaboration- partners will share the research and development costs and mobilize resources to screen a library of antiviral molecules for activity against SARS-CoV-2
• Janssen will utilize its antiviral expertise with Rega Institute for Medical Research’s high throughput screening experience & capabilities for the screening of compounds in Belgium

Click here ­to­ read full press release/ article |

Ref: J&J | Image: Janssen